Piedmont Atlanta Hospital is the first enrolled site in the U.S. for the COVE Transplant clinical trial, which will study Moderna’s COVID-19 vaccine on liver or kidney transplant recipients.

Raymond Rubin, M.D., chief scientific officer of Piedmont Transplant Institute, is serving as coordinating principal investigator for the study. The study’s goal is to enroll approximately 220 organ recipients at least six months after their transplant and 20 patients who have not received organ transplants - the control group.

Participants are required to return to the study site seven days after receiving each of their injections.

Participants must be at least 18 years old, not have a known history of COVID-19 infection or close contact with a person who has a COVID-19 infection within two weeks of vaccine administration, not have received a prior vaccination against COVID-19 and must not be pregnant or breastfeeding.

Piedmont Transplant has the largest abdominal transplant program in Georgia and is one of the top 15 programs nationally. It also has the largest adult liver transplant program in Georgia and ranks No. 8 in the country by volume.

For more information, visit piedmont.org.

Support Local Journalism

Now, more than ever, residents need trustworthy reporting—but good journalism isn’t free. Please support us by purchasing a digital subscription. Your subscription will allow you unlimited access to important local news stories. Our mission is to keep our community informed and we appreciate your support.

0
0
0
0
0

Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.